Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Alexandre Bart

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Journal of AIDS & Clinical Research|November 21, 2015
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive IndividualsJonathan D Fuchs, Pierre-Alexandre Bart, Nicole Frahm, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
The European Respiratory Journal|May 28, 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesMarina Tadolini, Luigi Ruffo Codecasa, José-María García-García, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Journal of AIDS & Clinical Research|November 21, 2015
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive IndividualsJonathan D Fuchs, Pierre-Alexandre Bart, Nicole Frahm, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
The European Respiratory Journal|May 28, 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesMarina Tadolini, Luigi Ruffo Codecasa, José-María García-García, et al.
The European Respiratory Journal|October 12, 2023
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort, Nicolas Casco, Alberto Levi Jorge, et al.
Pageof 10